2025-03-13

Our Lives after the AI Revolution - Answering the Hard Questions | EP #155

Recorded as a live audience Q&A rather than the usual panel format, Peter Diamandis fields questions on purpose in a post-work AI world, AI safety and data quality, the future of food, AI-governed nations, longevity economics, and education reform. He argues the real risk is human misuse of AI in the next five to seven years rather than AI itself, that longevity and AI are the two coming multi-trillion-dollar markets, and that schools should teach kids to find their passion and ask great questions rather than fear AI tools. He closes by urging the audience to actually try AI chatbots themselves and describing AI as a thinking partner that can model other perspectives.

▶ Watch on YouTube

Topics

Purpose in a post-work, AI-abundant world AI ▶ 1:35

Responding to an audience member's fear that robots and longevity will leave people without purpose, Diamandis says the real challenge ahead is one of purpose, not survival.

AI data quality and 'garbage in, garbage out' AI ▶ 4:51

An audience member worries AI training data from social media is unverified; Diamandis reframes AI safety as a parenting problem, citing Mo Gawdat's 'Scary Smart' Superman analogy.

Superintelligence timeline and risk window AI ▶ 5:50

Diamandis says mature superintelligence will be benevolent, but the next five to seven years of human misuse of early AI systems is the real danger.

Future of food and land use Biotech ▶ 7:44

Diamandis discusses replacing livestock farming with vertical farms and cultured meat to reduce humanity's footprint on the planet.

AI-governed nations and the Latin America opportunity Geopolitics ▶ 9:30

Asked how to maximize Latin America's opportunity, Diamandis advises building new nations or companies around AI governance, citing Abu Dhabi, and says AI will become the world's best teacher and physician.

El Salvador as a longevity hub Geopolitics ▶ 10:35

Diamandis describes pitching El Salvador's president on turning the country into a regulatory-arbitrage longevity and health destination.

Longevity economics and gene therapy costs Longevity ▶ 12:03

Diamandis explains Fountain Life's pricing, argues real longevity treatments will be gene therapies, and predicts their costs will collapse the way mRNA vaccine costs did.

Reinventing education for an AI world Other ▶ 15:34

Diamandis says schools are broken and should teach kids to find their passion and ask great questions rather than fear AI tools.

VR as the future of experiential learning Other ▶ 17:33

Diamandis envisions VR letting students live history firsthand, like meeting a simulated Socrates in ancient Greece, and urges the audience to try AI chatbots hands-on.

Using AI as a thinking partner AI ▶ 19:46

Answering a question from the host's own ChatGPT, Diamandis says human stubbornness, not technology, is the biggest obstacle to abundance, and describes using AI to model a negotiation opponent's perspective.

Predictions made

open Peter Diamandis: Affordable, effective longevity treatments will be widely available to everyone.

· due: 2040 · ▶ watch

“I think we'll see this by 2040”

Your call:

open Peter Diamandis: The next several years are the most dangerous window for AI misuse before systems mature into safe superintelligence.

· due: 2030-2032 · ▶ watch

“it's the next five six seven years that we have to be critically careful about”

Your call:

open Peter Diamandis: AI will become the best physician and best teacher for everyone, driving education and medical costs toward zero.

· due: unspecified · ▶ watch

“an AI will become your best physician and the cost of education and the cost of medical care will precipitously drop toward zero”

Your call:

open Peter Diamandis: Superintelligent AI systems, as they mature, will become abundance-loving and peace-loving rather than hostile.

· due: unspecified · ▶ watch

“the most intelligent systems as they mature to digital super intelligence will be abundance loving... peace loving”

Your call:

open Peter Diamandis: Gene-therapy-based longevity treatments will eventually become cheap and globally available, following the mRNA vaccine cost-collapse pattern.

· due: unspecified · ▶ watch

“these Therapeutics when they actually work are going to be cheap and available to everybody”

Your call:

Numbers that matter

One-third of Earth's non-ice land mass is used to grow crops for livestock Cited to argue for vertical farms and cultured meat as replacements for traditional livestock farming.
Fountain Life's full-body diagnostic 'upload' costs $19,500 (a cheaper version is $6,500) Illustrates the current high cost of longevity diagnostics before Diamandis expects it to demonetize.
An mRNA vaccine is essentially a gene therapy that can be produced for about $1 per dose at scale Used as proof that gene therapies can become cheap when manufactured at billions of doses.
A study by London Business School, Oxford, and Harvard found one added productive year of longevity is worth $38 trillion to the global economy Basis for Diamandis's claim that longevity is a multi-trillion-dollar market.
The first cell phone cost about $100,000 and dropped calls every block; today there are about 8 billion phones costing about $40 Used as an analogy for how the cost of new technology, including longevity treatments, collapses at scale.

Worth digging into

🕳️ Mo Gawdat's 'Scary Smart' AI-parenting analogy

Frames AI alignment as child-rearing, where the values given to AI determine whether it becomes a hero or a villain, like Superman landing in Kansas versus the Bronx.

🕳️ El Salvador as a longevity/health regulatory-arbitrage hub

Diamandis says he discussed turning El Salvador into a dedicated longevity-health nation with its president, a concrete policy experiment worth tracking.

🕳️ Abu Dhabi's AI governance transformation

Diamandis cites Abu Dhabi 'transforming to an AI governance' model as a template for new nations and companies, a real-world test of AI-run governance.

🕳️ The $38 trillion longevity-year study

The eye-popping valuation of a single added healthy year underlies Diamandis's entire longevity economic argument, and the study's methodology deserves scrutiny.